Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Carl Icahn Cuts His Netflix Stake in Half, Makes Giant Profit

Carl Icahn, Netflix: In a 13D filing just reported to the SEC, Carl Icahn disclosed a 4.5% stake in Netflix, Inc. (NASDAQ:NFLX), about half what he had owned previously. Netflix stock is down after hours as a result, and here’s what Icahn had to say via Twitter:

Screen Shot 2013-10-22 at 4.53.59 PM

The shares were sold from the Sargon portfolio, managed by Icahn’s son Brett, and David Schechter. The shares have been sold after Carl Icahn’s decision, based on the 457% growth of the price of the held shares, purchased at $58 apiece. To sell the shares Carl Icahn and Icahn Enterprises signed an agreement with Brett Icahn and David Schechter, in terms of which the latter will still get compensations based on the performance of Netflix’ stock, Icahn said in a press release.

Brett Icahn and David Schechter also said that despite the share price growth since the original investment, they still consider the stock as being undervalued. Since the low subscription price of Netflix of $7.99 per month, and the high-quality content makes Netflix an attractive bargain for consumers, the managers of the Sargon Portfolio believe that the company has a potential to add more subscribers, and with the currently low price, it might consider slightly increasing the monthly subscription fee, which will significantly increase the revenue of the company.

Disclosure: none

Recommended Reading:

Poker Night on Wall Street: The Unofficial Odds

Sigma Designs: Raging Capital Management Decreases Position to Below 5%

Hedge Fund News: Stanley Druckenmiller Calls Himself ‘Washed Up,’ John Paulson & Chris Hohn

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!